Health
Why Starting Colon Cancer Screenings at 40 Could Be a Lifesaver
Medical professionals are raising alarms over the increasing incidence of colon cancer among younger populations, prompting discussions about the need for earlier screenings. The American Cancer Society (ACS) identifies colorectal cancer as the third most prevalent cancer in both men and women. Statistically, approximately one in 24 men and one in 26 women will face a colon cancer diagnosis in their lifetime. However, experts caution that these numbers might not improve unless screening protocols are adjusted to begin at an earlier age.
Traditionally associated with older adults, colorectal cancer is now increasingly affecting younger individuals. This shift is attributed to various factors, including dietary changes prevalent in modern lifestyles. According to the Colorectal Cancer Alliance, it is “currently the deadliest cancer among young men and the second deadliest among young women.”
A 2024 CDC analysis highlighted “concerning shifts” in colorectal cancer rates, particularly among those under 45. While multiple theories exist regarding this trend, the Western diet, characterized by high-fat and low-fiber processed foods, is frequently cited as a significant contributor. Researchers suggest that this diet could lead to changes in the gut biome, increasing susceptibility to colon cancer.
In response to these developments, the U.S. Preventive Services Task Force (USPSTF) revised its screening recommendations in 2021, lowering the age from 50 to 45 for average-risk adults. Yet, scientists now advocate for screenings to commence even earlier, at age 40. A study published in JAMA Oncology supports this recommendation, demonstrating that initiating screenings at 40 could reduce colon cancer cases by 21% and mortality by 39% compared to starting at 50.
Dr. Coral Olazagasti from the University of Miami Sylvester Comprehensive Cancer Center, although not involved in the study, expressed concern over the trend. “In the past, you would think cancer was a disease of the elderly population. But now we’ve been seeing trends in recent years of people getting diagnosed with cancer earlier and earlier,” Olazagasti noted.
The study utilized the fecal immunochemical test (FIT) to assess its effectiveness in younger age groups. With 263,125 participants aged 40 to 49, the research underscored FIT’s potential in reducing cancer incidence and mortality. “These findings highlight FIT’s effectiveness in this younger age group and support recommendations to lower the screening initiation age,” the study authors concluded.
Other factors potentially contributing to early-onset colon cancer include sedentary lifestyles and early-life antibiotic exposure. If individuals experience symptoms such as rectal bleeding, abdominal pain, or changes in bowel habits, or have a family history of colorectal cancer, they should consult their healthcare provider for guidance.
Let us know what you think, please share your thoughts in the comments below.
